Delisting risk
Elutia
Develops drug-eluting biomatrices for surgical reconstruction and implanted-device complications.
$0.8800
After-hours close−0.00 (−0.18%)
At close$0.8816(+0.18%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 25.20%
Shares outstanding 44.21M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Kevin Rakinincl. HighCape Partners GP II, L.P., HighCape Partners, L.P. +7 more | 13.00% | 5.24M | 13D | Dec 15, 2025 ↗ |
| Nantahala Capital Management, LLC | 9.99% | 4.12M | 13G | Feb 13, 2026 ↗ |
| Orin Hirschman | 7.60% | 3.07M | 13G | Jan 28, 2026 ↗ |
| Knollwood Investment Advisory, LLC | 6.30% | 2.56M | 13G | Feb 13, 2026 ↗ |
| SilverArc Capital Management, LLC | 5.90% | 1.78M | 13G | Feb 12, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| HighCape Capital, L.P. | director, 10 percent owner: | 9.52M | 21.53% | Mar 13, 2025 |
| Matthew Ferguson | officer: CHIEF FINANCIAL OFFICER | 480.1K | 1.09% | Jun 12, 2026 |
| C. Randal Mills | director, officer: PRESIDENT AND CEO | 441.2K | 1.00% | Jun 22, 2026 |
| Kevin Rakin | director, 10 percent owner: | 398.5K | 0.90% | Jun 2, 2026 |
| Guido J. Neels | director | 125.0K | 0.28% | Apr 14, 2026 |
| Michelle LeRoux Williams | officer: CHIEF SCIENTIFIC OFFICER | 118.1K | 0.27% | Jun 12, 2026 |
| David Colpman | director | 31.1K | 0.07% | Dec 18, 2025 |
| Brigid Makes | director | 27.0K | 0.06% | Dec 18, 2025 |
2 ten-percent owners hold 10.76M shares by Form 4, outside the officers-and-directors figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 30, 2026 | Guido J. Neelsdirector | Purchase | 20,000 | $1.04 | 118,750 |
| Jan 30, 2026 | Kevin Rakindirector, 10 percent owner: | Purchase | 70,000 | $1.06 | 196,120 |
| Jan 28, 2026 | Guido J. Neelsdirector | Purchase | 15,000 | $1.06 | 83,750 |
| Jan 29, 2026 | Guido J. Neelsdirector | Purchase | 15,000 | $1.06 | 98,750 |
| Dec 17, 2025 | Kevin Rakindirector, 10 percent owner: | Purchase | 50,000 | $0.5199 | 322,419 |
| Dec 17, 2025 | Matthew Fergusonofficer: CHIEF FINANCIAL OFFICER | Purchase | 60,000 | $0.5300 | 447,110 |
| Dec 17, 2025 | C. Randal Millsdirector, officer: PRESIDENT AND CEO | Purchase | 3,000 | $0.5100 | 379,204 |
| Dec 17, 2025 | Brigid Makesdirector | Purchase | 25,000 | $0.5200 | 27,000 |
| Dec 17, 2025 | David Colpmandirector | Purchase | 12,500 | $0.5100 | 31,098 |
| Dec 1, 2025 | Matthew Fergusonofficer: CHIEF FINANCIAL OFFICER | Purchase | 4,500 | $0.6500 | 373,571 |
CongressHouse and Senate disclosures
Not reported.